LYTENAVA

Product NDC
82491-025
11-digit product format
824910025
Labeler code
82491
Product ID
82491-025_c397a7ca-1508-46af-ae5b-48956181d281
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
bevacizumab-vikg
Dosage form
INJECTION
Route
INTRAVITREAL
Labeler
Outlook Therapeutics, Inc.
Application
BLA761320
Marketing category
BLA
Marketing start
2026-07-16
Substance
BEVACIZUMAB
Active strength
1.25 mg/1
Pharmacologic classes
Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
LYTENAVA
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BEVACIZUMAB1.25 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2S9ZZM9Q9VInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2749110Internal RxNorm lookup
2749117Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
7f9a3014-b3d4-4943-a83a-92a77d8f947cAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LYTENAVABEVACIZUMAB-VIKGOutlook Therapeutics, Inc.7f9a3014-b3d4-4943-a83a-92a77d8f947c2026-10-29Warnings, Adverse reactionsExact identifier
application number: BLA761320
ndc (product): 82491-025

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761320Lytenavabevacizumab-vikg351(a)Rx2026-10-01

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
82491-025-10824910025101 VIAL, GLASS in 1 CARTON (82491-025-10) / 1 INJECTION in 1 VIAL, GLASS2026-07-16NoNoCurrent